Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Tianjin Chase Sun Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥153.30 Million ≈ $22.43 Million USD) by net assets (CN¥8.80 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

Cash flow conversion efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Tianjin Chase Sun Pharmaceutical Co Ltd for real-time trading data and today's change.

Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Tianjin Chase Sun Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Tianjin Chase Sun Pharmaceutical Co Ltd (300026) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Concord Biotech Limited NSE:CONCORDBIO	N/A
TriMas Corporation NASDAQ:TRS	0.095x
Shenzhen Injoinic Technology Co. Ltd. A SHG:688209	N/A
Zhejiang Construction Investment Group Co Ltd SHE:002761	0.029x
Lotte Chemical Corp KO:011170	-0.034x
Vistance Networks, Inc. NASDAQ:VISN	-0.029x
Orezone Gold Corporation AU:ORE	0.302x
Hugel Inc KQ:145020	0.038x

Annual Cash Flow Conversion Efficiency for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. Review 300026 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.80 Billion ≈ $1.29 Billion	CN¥852.24 Million ≈ $124.71 Million	0.097x	-43.86%
2023-12-31	CN¥8.87 Billion ≈ $1.30 Billion	CN¥1.53 Billion ≈ $223.90 Million	0.173x	+95.92%
2022-12-31	CN¥8.46 Billion ≈ $1.24 Billion	CN¥745.35 Million ≈ $109.07 Million	0.088x	+78.85%
2021-12-31	CN¥7.95 Billion ≈ $1.16 Billion	CN¥391.60 Million ≈ $57.30 Million	0.049x	+85.09%
2020-12-31	CN¥7.39 Billion ≈ $1.08 Billion	CN¥196.66 Million ≈ $28.78 Million	0.027x	-12.96%
2019-12-31	CN¥7.07 Billion ≈ $1.03 Billion	CN¥216.10 Million ≈ $31.62 Million	0.031x	-48.22%
2018-12-31	CN¥6.58 Billion ≈ $962.28 Million	CN¥388.19 Million ≈ $56.81 Million	0.059x	-48.25%
2017-12-31	CN¥6.51 Billion ≈ $952.41 Million	CN¥742.38 Million ≈ $108.63 Million	0.114x	+53.72%
2016-12-31	CN¥6.04 Billion ≈ $883.64 Million	CN¥448.08 Million ≈ $65.57 Million	0.074x	+224.40%
2015-12-31	CN¥5.29 Billion ≈ $774.07 Million	CN¥121.00 Million ≈ $17.71 Million	0.023x	-64.02%
2014-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥149.94 Million ≈ $21.94 Million	0.064x	-24.62%
2013-12-31	CN¥1.70 Billion ≈ $249.14 Million	CN¥143.60 Million ≈ $21.01 Million	0.084x	-23.17%
2012-12-31	CN¥1.39 Billion ≈ $202.91 Million	CN¥152.21 Million ≈ $22.27 Million	0.110x	+223.42%
2011-12-31	CN¥1.05 Billion ≈ $153.65 Million	CN¥35.64 Million ≈ $5.22 Million	0.034x	-19.44%
2010-12-31	CN¥1.10 Billion ≈ $160.63 Million	CN¥46.25 Million ≈ $6.77 Million	0.042x	-71.09%
2009-12-31	CN¥926.88 Million ≈ $135.63 Million	CN¥135.06 Million ≈ $19.76 Million	0.146x	-76.47%
2008-12-31	CN¥125.51 Million ≈ $18.37 Million	CN¥77.74 Million ≈ $11.38 Million	0.619x	-47.33%
2007-12-31	CN¥61.24 Million ≈ $8.96 Million	CN¥72.01 Million ≈ $10.54 Million	1.176x	+1943.30%
2006-12-31	CN¥21.28 Million ≈ $3.11 Million	CN¥1.22 Million ≈ $179.15K	0.058x	--

About Tianjin Chase Sun Pharmaceutical Co Ltd

SHE:300026 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.39 Billion

CN¥9.49 Billion CNY

Market Cap Rank

#7249 Global

#1479 in China

Share Price

CN¥3.16

Change (1 day)

+0.64%

52-Week Range

CN¥2.90 - CN¥3.95

All Time High

CN¥9.11